Once again , you make up figures . The finance costs as listed in H1 results were A$15.5M , therefore for 12 months A$31M .I agree the finance costs will be higher in H2 , because of re-rate with banks and a higher interest rate than in H1 , but no where near A$45m for the half. As for your 10 year figure on dividend, who knows , not I and certainly not you.
- Forums
- ASX - By Stock
- SGH
- Ann: FY16 Earnings Guidance-SGH.AX
Ann: FY16 Earnings Guidance-SGH.AX, page-40
-
- There are more pages in this discussion • 419 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SGH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online